1    INTRODUCTION    
 1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology 
    2.1 Research Methodology Steps 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology 
    2.4 Market Data Validation and Triangulation 
    2.5 Assumptions for the Study

3 Executive Summary 

4 Premium Insights 
    4.1 Insulin Delivery Devices: Market Snapshot 
    4.2 Geographic Analysis: Market, By Type (2019) 
    4.3 Insulin Delivery Devices Market Size, By End User, 2019 vs 2025 (USD Billion) 
    4.4 Geographic Snapshot of the Market

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                    5.2.1.1 Growing Diabetic Population
                    5.2.1.2 Technological Advancements in Insulin Delivery Devices
                    5.2.1.3 Favorable Reimbursement Environment and Government Support in Selected Countries
                    5.2.1.4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices
           5.2.2 Restraints
                    5.2.2.1 Poor Reimbursement Structure in Developing Countries
                    5.2.2.2 Needle Anxiety in Patients to Affect the Growth of the Pen Needles and Syringes Market
                    5.2.2.3 Oral Insulin as an Alternative Drug Delivery Method
                    5.2.2.4 Issues Associated With the Reuse of Pen Needles and Infusion Sets
           5.2.3 Opportunities
                    5.2.3.1 Increasing Research and Development Activities
                    5.2.3.2 Increasing Diabetes-Related Health Expenditure in Emerging Economies
                    5.2.3.3 Safety Needles
           5.2.4 Challenge
                    5.2.4.1 Severe Shortage of Endocrinologists in the U.S.

6 Insulin Delivery Devices Market, By Type 
    6.1 Introduction 
    6.2 Pens 
           6.2.1 Reusable Insulin Pens
           6.2.2 Disposable Insulin Pens
    6.3 Insulin Pumps 
           6.3.1 External/Tethered Pumps
           6.3.2 Patch Pumps
    6.4 Pen Needles 
           6.4.1 Standard Pen Needles
           6.4.2 Safety Pen Needles
    6.5 Insulin Syringes 
    6.6 Other Insulin Delivery Devices

7 Insulin Delivery Devices Market, By End User 
    7.1 Introduction 
    7.2 Patients/Homecare 
    7.3 Hospitals & Clinics

8 Insulin Delivery Devices Market, By Region 
    8.1 Introduction 
    8.2 North America 
           8.2.1 U.S.
                    8.2.1.1 Rising Prevalence of Diabetes and Favorable Reimbursement Scenario
                    8.2.1.2 Awareness Activities to Stimulate Usage of Insulin Delivery Devices in the U.S.
                    8.2.1.3 Growing Venture Capital Investments and Issuance of Ipos
                    8.2.1.4 FDA Approvals to Increase the Commercial Availability of Insulin Delivery Devices
           8.2.2 Canada
                    8.2.2.1 High Prevalence of Diabetes and Favorable Reimbursement for Insulin Delivery Devices
                    8.2.2.2 Regulations for the Usage of Safety-Engineered Needles
    8.3 Europe 
           8.3.1 Eu’s Directive on the Prevention of Sharps Injuries in Hospitals and the Healthcare Sector
           8.3.2 Germany
                    8.3.2.1 High Prevalence of Diabetes, Favorable Reimbursement for Insulin Devices
           8.3.3 France
                    8.3.3.1 High Insurance Coverage and Increasing Affordability
                    8.3.3.2 Conferences and Exhibitions
           8.3.4 U.K.
                    8.3.4.1 Role of Diabetes U.K. in Research and Diabetes Care
                    8.3.4.2 Low Insulin Pump Penetration in the U.K.
           8.3.5 Rest of Europe (RoE)
                    8.3.5.1 Spain: Regulations for Mandatory Use of Safety Needles, Large Diabetic Population
                    8.3.5.2 Italy: Regional Variations in Terms of Coverage and Benefits to Hinder Market Growth
                    8.3.5.3 Strong Presence of Major Insulin Delivery Device Manufacturers in RoE Countries
                    8.3.5.4 Large Diabetic Populations in Russia, Romania, Poland, and Portugal
    8.4 Asia- Pacific 
          8.4.1 High Diabetes Incidence and Population in Asia-Pacific
          8.4.2 Partnerships Among Global and Local Players in Asia-Pacific
          8.4.3 Japan: High Adoption of Insulin Pens and Approval of Injectable Insulin
          8.4.4 India: Low Penetration of Pen Needles & Pumps and Low Awareness to Restrain Market Growth
          8.4.5 Government Initiatives in Singapore
          8.4.6 Vietnam, A Potential Market for Insulin Delivery Devices
          8.4.7 Australia: Amendments in Ndss to Broaden Patient Access to Diabetes Products
    8.5 RoW 
          8.5.1 Increasing Diabetic Population
          8.5.2 Rising Awareness on Diabetes
          8.5.3 Conferences

9 Competitive Landscape 
    9.1 Overview 
    9.2 Market Share Analysis 
    9.3 Competitive Situation and Trends 
           9.3.1 Marketing and Promotion
           9.3.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
           9.3.3 Product Launches
           9.3.4 Expansions
           9.3.5 Other Strategies

10 Company Profiles 
     10.1 Introduction 
     10.2 Becton, Dickinson and Company 
     10.3 Novo Nordisk A/S 
     10.4 Medtronic PLC 
     10.5 Sanofi 
     10.6 ELI Lilly and Company 
     10.7 Ypsomed Holding AG 
     10.8 Animas Corporation (Johnson and Johnson) 
     10.9 Tandem Diabetes Care, Inc. 
     10.10 Insulet Corporation 
     10.11 Biocon Limited